ABOS EPS Estimates
Acumen Pharmaceuticals, Inc.
$1.75
-$0.07(-3.86%)
31
Overall
60
Value
18
Tech
15
Quality
Market Cap
$126.19M
Volume
619.66K
52W Range
$1.50 - $3.60
Target Price
$7.75
ABOS EPS estimates: the consensus estimate for Acumen Pharmaceuticals, Inc.'s current fiscal year is -$1.60 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ABOS EPS Estimates
- EPS estimate, current quarter
- $-0.43
- EPS estimate, next quarter
- $-0.32
- EPS estimate, current year
- $-1.60
- EPS estimate, next year
- $-1.67
- EPS growth, 3-year
- -23.57%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.00 |
| 2024 | $-1.71 |
| 2023 | $-1.08 |
| 2022 | $-1.06 |
| 2021 | $-5.02 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABOS | $1.75 | -3.9% | 619.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Acumen Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW